RE:RE:RE:When you issue converts...I wouldnt describe the discussion as "empty". If just from an emotional/psycological point of view its important to know that these sorts of factors exist in the market and that they can have impacts on various timescales, it's preferrable to being in the dark about what is driving the SP.
The important point for longs is at some point the Trogarzo story will come to dominate the SP again the way it has dominated the turn around in fortunes for the company over the past 2+ years.
jfm1330 wrote: Sorry, but a lot of empty discussions about why it's down. You don't need to be a very long shareholder to remember a similar shift for no reasons. From mid-January to mid-Februray this year it went from 8.21 $ to 6.86$, a drop of 16.5% in a month and by mid-March it was at 9.95$. Now we have a drop from 14.48 $ to 11.74 $, a drop of 19%. This is pretty similar to me. There is no reasons to explain that other than some are taking profits, like some were taking profits in mid-February before the FDA answer on approval, even though approval was very likely to be given. The same now, some take profits out of fear on Trogarzo sales numbers, but there is no reasons to think they won't be good. This is just normal noise happening with fast growing stocks.